Cancer Immunotherapy With Immunomodulatory Anti-Cd137 and Anti-Pd-1 Monoclonal Antibodies Requires BATF3-Dependent Dendritic Cells
Cancer Discovery - United States
doi 10.1158/2159-8290.cd-15-0510
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 22, 2015
Authors
Publisher
American Association for Cancer Research (AACR)